Nanoparticles: pharmacological and toxicological significance

By C. Medina, M. Santos-Martinez, A. Radomski, O. Corrigan, M. Radomski. British Journal of Pharmacology, 2007

713 citations recorded by the source corpus.

Subfields: Biomaterials, Materials Chemistry, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/90f2c095cc1f4ade32066c06af34fae30221fc74

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. Rishi Shanker
2. S. Jin
3. Sumit Arora
4. Nandita DasGupta
5. Ashutosh Kumar
6. T. R. Pisanic
7. V. Shubayev
8. S. Ranjan

In Materials Chemistry

1. Vyom Sharma
2. A. Dhawan
3. S. Jin
4. Sumit Arora
5. Nandita DasGupta
6. T. R. Pisanic
7. V. Shubayev
8. S. Ranjan

Citations in the corpus

• Review of health safety aspects of nanotechnologies in food production. (2009, background): “Reducing the size of the encapsulates into the nanoscale offers opportunities related to prolonged gastrointestinal retention time caused by bio-adhesive improvements in the mucus covering the intestinal epithelium (Chen et al., 2006b; Medina et al., 2007).”
• Toxicity assessment of nanomaterials: methods and challenges (2010, background): “Nanoparticles have been shown to produce cytotoxic, genotoxic, inflammatory and oxidative stress responses in different mammalian cells in vitro [8–14].”
• Magnetic nanoparticles for theragnostics (2009, background): “Current studies on mechanisms of nanotoxicity overwhelmingly point to OSmediated activation of proinflammatory cytokines and MAPK signaling pathways in respiratory and gastrointestinal tracts, blood cells, skin and the nervous system, as carefully reviewed [14,77,79,103].”
• Nanotechnology in agro-food: From field to plate (2015, background): “For effective delivery systems, the encapsulated compounds should be delivered to the target sites, should be maintained at a suitable concentration for prolonged time periods and the degradation should be prevented; which has been achieved after various modifications by researchers (Chen, Remondett”
• Nanotoxicology and in vitro studies: the need of the hour. (2012, background): “…nanoparticles demonstrate distribution of particles to the lungs, liver, heart, kidney, spleen and brain (BeruBe et al., 2007; Hagens et al., 2007; Medina et al., 2007; Oberdorster et al., 2002) and clearance via phagocytosis in the alveolar region by macrophages (Curtis et al., 2006; Garnett and…”
• Natural nanoclays: applications and future trends – a chilean perspective (2009, neutral): “(Medina et al., 2007).”